Redefining BMI: The Body, Mind, and Inflammation Trial
Eligible age
18–25 yrs
Accepts
Women
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Emerging adulthood (18-25 years of age) is a critical developmental window to promote weight management and cardiometabolic health, particularly for emerging adult women. The primary purpose of this study is to test the preliminary efficacy of the intensive lifestyle intervention for EA women in reducing adiposity, as well as improving biomarkers of inflammation and metabolic risk over 12 months compared with a traditional behavioral weight loss intervention. This treatment program will be tested in emerging adult (EA) women ages 18-25 years old with a BMI of 25-50 kg/m\^2.
Sponsor: Virginia Commonwealth University
You may qualify if…
- ✓ Ages 18-25 years
- ✓ Body mass index (BMI) 25-50 kg/m\^2
- ✓ Female
You may not qualify if…
- ✕ Currently pregnant or lactating
- ✕ Current involvement in a weight loss program or current use of weight loss medication
- ✕ Lost \>5% of their body weight in the previous 3 months
- ✕ Uncontrolled medical conditions that may pose a safety issue given the recommendations for the diet and unsupervised physical activity
- ✕ Diagnosis of type 2 diabetes and/or impaired fasting blood glucose
- ✕ Diagnosis of type 1 diabetes
- ✕ Rheumatologic and gastrointestinal conditions associated with severe systemic inflammation
- ✕ Medical conditions resulting in known perturbations in the hypothalamic-pituitary-adrenal axis
Where it's recruiting
Richmond
Source: ClinicalTrials.gov · NCT06532747 · last updated 2026-05-06